Recent Patents on Anti-Infective Drug Discovery

Dieter Kabelitz  
Institute of Immunology
Universitätsklinikum Schleswig-Holstein
Campus Kiel
Arnold-Heller-Straße 3
Kiel, D-24105
Germany

Back

Emerging Drugs for the Treatment of Human Immunodeficiency Virus

Author(s): Girish M. Bhopale

Affiliation: Research and Development Division, Hindustan Antibiotics Ltd., Pimpri, Pune, 411018, India.

Keywords: AIDS, antiretroviral drugs, clinical studies, emerging drugs, HIV, patents, NRTIs, zidovudine, Rilpivirine, Apricitabine

Abstract:

Rapid emergence of drug resistant Human Immunodeficiency virus (HIV) variants and severe side effects of anti-HIV drugs limit the efficacy of existing anti-HIV therapies. Efforts are being made to develop newer anti-HIV agents. Few newer anti-HIV agents reached the different clinical phases of development and appear promising for future therapy. The present article highlights the current status of available anti-HIV drugs, emerging anti-HIV drug agents and recent anti-HIV drugs patents information.

Reprint ePrint Rights & PermissionsPrintExport

Article Details

VOLUME: 7
ISSUE: 1
Page: [45 - 52]
Pages: 8
DOI: 10.2174/157489112799829729